# Vitromed GmbH

- Location (FDA's records): Langenfeld, DE
- FDA decisions: 7 (2020–2025): 7 510(k) clearances
- Product codes: MQL (6), MQH (1)
- 510(k) review time since 2016: median 258 days, against 199 for FDA's reviews in the same codes and years (1 of 6 faster)
- Predicates its devices cite: 6 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Shenzhen Vitavitro Biotech Co., Ltd.: 1 (https://510kreport.com/company/shenzhen-vitavitro-biotech)
- Invitrocare, Inc.: 1 (https://510kreport.com/company/invitrocare)
- Research Instruments, Ltd.: 1 (https://510kreport.com/company/research-instruments)
- Origio A/S: 1 (https://510kreport.com/company/origio-a-s)
- Kitazato Corporation: 1 (https://510kreport.com/company/kitazato)
- Origio A/S, A Coopersurgical Company: 1 (https://510kreport.com/company/origio-a-s-a-coopersurgical)

## Recent decisions
- K241833: V-GRAD (Mar 21, 2025)
- K240176: V-VITFREEZE and V-VITWARM (Sep 13, 2024)
- K232125: V-PVP (Mar 20, 2024)
- K222606: V-Hyadase (May 26, 2023)
- K223117: V-Sperm Wash (Jan 31, 2023)
- K193285: V-Onestep (Nov 20, 2020)
- K192146: V-Denupet (Jan 28, 2020)

Source page: https://510kreport.com/company/vitromed